Glycofren

Glycofren is a prescription oral medication that contains metformin hydrochloride as its active ingredient. It belongs to the biguanide class of antidiabetic drugs and is marketed in the European Union. The product is formulated for oral administration and is used to improve blood glucose control in patients with type 2 diabetes mellitus. Glycofren is available only with a doctor's prescription. It is supplied in tablet form.

Glycofren is indicated for the management of elevated blood glucose levels associated with type 2 diabetes mellitus, and may be used as part of a comprehensive treatment plan that includes diet, exercise, and other glucose‑lowering agents.

- Adjunct therapy when diet and exercise alone do not achieve target glycemic control. - Combination with other oral antidiabetic agents such as sulfonylureas or DPP‑4 inhibitors. - Use in patients with mild to moderate renal impairment under clinical supervision. - Off‑label consideration for polycystic ovary syndrome when prescribed by a specialist. - May be prescribed in elderly patients after dose adjustment.

Like other metformin products, Glycofren can cause a range of side effects that vary in frequency and severity.

Common: - Nausea, vomiting, or loss of appetite. - Diarrhea or abdominal cramping. - Metallic taste in the mouth. - Weight loss or decreased appetite.

Serious: - Lactic acidosis, a rare but life‑threatening metabolic condition. - Severe skin reactions such as Stevens‑Johnson syndrome. - Marked hypoglycemia when combined with insulin or secretagogues. - Persistent gastrointestinal distress leading to dehydration.

Before starting Glycofren, healthcare providers assess several clinical factors to minimize risks and ensure safe use.

- Assess renal function; contraindicated in severe renal impairment. - Monitor liver enzymes periodically during therapy. - Evaluate for signs of heart failure or hypoxia. - Use caution in patients with a history of alcohol abuse. - Pregnancy and breastfeeding status should be reviewed; safety data are limited. - Adjust dose in elderly patients due to altered pharmacokinetics. - Regularly check vitamin B12 levels during long‑term treatment.

Glycofren may interact with other medicines, affecting blood glucose levels or increasing the risk of adverse events.

Avoid: - Concurrent use with iodinated contrast agents without adequate hydration. - Combination with other biguanides or high‑dose metformin formulations. - Co‑administration with potent CYP450 inhibitors that affect renal clearance.

Use with caution: - Sulfonylureas, meglitinides, or insulin, which may increase hypoglycemia risk. - Corticosteroids, thiazide diuretics, or beta‑blockers that can raise glucose levels. - Alcohol consumption, which may predispose to lactic acidosis. - Radiographic contrast studies; ensure proper hydration and monitoring.